Smad3-mediated upregulation of miR-21 promotes renal fibrosis

Journal of the American Society of Nephrology

Volumn 22, Issue 9, 2011, Pages 1668-1681

  Zhong, Xiang ^a,b   Chung, Arthur C K ^a   Chen, Hai Yong ^b   Meng, Xiao Ming ^b   Lan, Hui Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21; PLASMID VECTOR; SHORT HAIRPIN RNA PLASMID; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; KIDNEY FIBROSIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THERAPY EFFECT; UPREGULATION; URETER OBSTRUCTION;

EID: 80052316668     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010111168     Document Type: Article

References (54)

1. Stahl P.J., Felsen D.: Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: Implications for fibrosis in kidney disease. Am J Pathol 159: 1187-1192, 2001 (Pubitemid 32947947)
2. Remuzzi G., Bertani T.: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998 (Pubitemid 28516069)
3. Iwano M., Neilson E.G.: Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279-284, 2004 (Pubitemid 38582300)
4. Muller G.A., Zeisberg M., Strutz F.: The importance of tubulointerstitial damage in progressive renal disease. Nephrol Dial Transplant 15[Suppl 6]: 76-77, 2000
5. Boor P., Ostendorf T., Floege J.: Renal fibrosis: Novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656, 2010
6. Hayashida T., Schnaper H.W.: High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal-regulated kinase and protein kinase Cdelta activities in human mesangial cells. J Am Soc Nephrol 15: 2032-2041, 2004 (Pubitemid 39031342)
7. Hoffman B.B., Sharma K., Ziyadeh F.N.: Potential role of TGF-beta in diabetic nephropathy. Miner Electrolyte Metab 24: 190-196, 1998 (Pubitemid 28098191)
8. Schnaper H.W., Hayashida T., Hubchak S.C., Poncelet AC: TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 284: F243-F252, 2003
9. Zavadil J., Narasimhan M., Blumenberg M., Schneider R.J.: Transforming growth factor-beta and microRNA:MRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185: 157-161, 2007 (Pubitemid 46956856)
10. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., Natarajan R.: MicroRNA-192 in diabetic kidney glomeruli and its function in TGFbeta- induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437, 2007 (Pubitemid 46364176)
11. Chung A.C., Huang X.R., Meng X., Lan H.Y.: miR-192 mediates TGF-beta/ Smad3-driven renal fibrosis. J Am Soc Nephrol 21: 1317-1325, 2010
12. Jazbutyte V., Thum T.: MicroRNA-21: From cancer to cardiovascular disease. Curr Drug Targets 11: 926-935, 2010
13. Davis B.N., Hilyard A.C., Lagna G., Hata A.: SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61, 2008 (Pubitemid 351931982)
14. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A.: Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373-384, 2010
15. Chan J.A., Krichevsky A.M., Kosik K.S.: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005 (Pubitemid 40994386)
16. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., Engelhardt S.: MicroRNA- 21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984, 2008
17. Liu G., Friggeri A., Yang Y., Milosevic J., Ding Q., Thannickal V.J., Kaminski N., Abraham E.: miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597, 2010
18. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J.: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601, 2008 (Pubitemid 351627379)
19. Van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., Olson E.N.: Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032, 2008
20. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., Janssen J., Koppe C., Knolle P., Castoldi M., Tacke F., Trautwein C., Luedde, T.: Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53: 209-218, 2010
21. Yang F., Chung A.C., Huang X.R., Lan H.Y.: Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: The role of Smad3. Hypertension 54: 877-884, 2009
22. Zhou L., Fu P., Huang X.R., Liu F., Chung A.C., Lai K.N., Lan H.Y.: Mechanism of chronic aristolochic acid nephropathy: Role of Smad3. Am J Physiol Renal Physiol 298: F1006-F1017, 2010
23. Chung A.C., Zhang H., Kong Y.Z., Tan J.J., Huang X.R., Kopp J.B., Lan H.Y.: Advanced glycation end-products induce tubular CTGF via TGF-betaindependent Smad3 signaling. J Am Soc Nephrol 21: 249-260, 2010
24. Piek E., Ju W.J., Heyer J., Escalante-Alcalde D., Stewart C.L., Weinstein M., Deng C., Kucherlapati R., Bottinger E.P., Roberts A.B.: Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276: 19945-19953, 2001
25. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A.: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494, 2003 (Pubitemid 38056275)
26. Meng X.M., Huang X.R., Chung A.C., Qin W., Shao X., Igarashi P., Ju W., Bottinger E.P., Lan H.Y.: Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol 21: 1477-1487, 2010
27. Li T., Li D., Sha J., Sun P., Huang Y.: MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383: 280-285, 2009
28. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H.: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033, 2008
29. Zhou X., Zhang J., Jia Q., Ren Y., Wang Y., Shi L., Liu N., Wang G., Pu P., You Y., Kang C.: Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol Rep 24: 195-201, 2010
30. Ng Y.Y., Hou C.C., Wang W., Huang X.R., Lan, H.Y.: Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl: S83-S91, 2005
31. Lan H.Y., Mu W., Tomita N., Huang X.R., Li J.H., Zhu H.J., Morishita R., Johnson R.J.: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14: 1535-1548, 2003 (Pubitemid 36687055)
32. Hou C.C., Wang W., Huang X.R., Fu P., Chen T.H., Sheikh-Hamad D., Lan H.Y.: Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 166: 761-771, 2005 (Pubitemid 40315633)
33. Ka S.M., Huang X.R., Lan H.Y., Tsai P.Y., Yang S.M., Shui H.A., Chen A.: Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 18: 1777-1788, 2007
34. Zeisberg M., Hanai J., Sugimoto H., Mammoto T., Charytan D., Strutz F., Kalluri R.: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003 (Pubitemid 36889942)
35. Deelman L., Sharma K.: Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens 18: 85-90, 2009
36. Yu L., Border W.A., Anderson I., McCourt M., Huang Y., Noble N.A.: Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int 66: 1774-1784, 2004 (Pubitemid 41094301)
37. Yaswen L., Kulkarni A.B., Fredrickson T., Mittleman B., Schiffman R., Payne S., Longenecker G., Mozes E., Karlsson S.: Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood 87: 1439-1445, 1996 (Pubitemid 26056908)
38. Godwin J.G., Ge X., Stephan K., Jurisch A., Tullius S.G., Iacomini J.: Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 107: 14339-14344, 2010
39. Roy S., Khanna S., Hussain S.R., Biswas S., Azad A., Rink C., Gnyawali S., Shilo S., Nuovo G.J., Sen C.K.: MicroRNA expression in response to murine myocardial infarction: MiR-21 regulates fibroblast metalloprotease- 2 via phosphatase and tensin homologue. Cardiovasc Res 82: 21-29, 2009
40. White E.S., Atrasz R.G., Hu B., Phan S.H., Stambolic V., Mak T.W., Hogaboam C.M., Flaherty K.R., Martinez F.J., Kontos C.D., Toews G.B.: Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med 173: 112-121, 2006 (Pubitemid 43069796)
41. Wang B., Herman-Edelstein M., Koh P., Burns W., Jandeleit-Dahm K., Watson A., Saleem M., Goodall G.J., Twigg S.M., Cooper M.E., Kantharidis P.: E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 59: 1794-1802, 2010
42. Krupa A., Jenkins R., Luo D.D., Lewis A., Phillips A., Fraser, D.: Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 21: 438-447, 2010
43. Li J.H., Huang X.R., Zhu H.J., Oldfield M., Cooper M., Truong L.D., Johnson R.J., Lan H.Y.: Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: Implications for diabetic renal and vascular disease. Faseb J 18: 176-178, 2004
44. Li Y.G., Zhang P.P., Jiao K.L., Zou Y.Z.: Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with myocardial infarction. Microvasc Res 78: 393-404, 2009
45. Chung A.C., Huang X.R., Zhou L., Heuchel R., Lai K.N., Lan H.Y.: Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 24: 1443-1454, 2009
46. Chen H., Huang X.R., Wang W., Li J., Heuchel R.L., Chung A.C., Lan H.Y.: The protective role of Smad7 in diabetic kidney disease: Mechanism and therapeutic potential. Diabetes 60: 590-601, 2010
47. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., Deng C.: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18: 1280-1291, 1999 (Pubitemid 29110312)
48. Ju W., Ogawa A., Heyer J., Nierhof D., Yu L., Kucherlapati R., Shafritz D.A., Bottinger E.P.: Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 26: 654-667, 2006 (Pubitemid 43089776)
49. Koka V., Huang X.R., Chung A.C., Wang W., Truong L.D., Lan H.Y.: Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am J Pathol 172: 1174-1183, 2008 (Pubitemid 351671532)
50. Lan H.Y., Hutchinson P., Tesch G.H., Mu W., Atkins R.C.: A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry. J Immunol Methods 190: 1-10, 1996 (Pubitemid 26099973)
51. Huang X.R., Chung A.C., Zhou L., Wang X.J., Lan H.Y.: Latent TGF-beta1 protects against crescentic glomerulonephritis. J Am Soc Nephrol 19: 233-242, 2008 (Pubitemid 351240645)
52. Huang X.R., Chung A.C., Wang X.J., Lai K.N., Lan H.Y.: Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. Am J Physiol Renal Physiol 295: F118-F127, 2008
53. Kloosterman W.P., Wienholds E., De Bruijn E., Kauppinen S., Plasterk R.H.: In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 3: 27-29, 2006 (Pubitemid 43135345)
54. Obernosterer G., Martinez J., Alenius M.: Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat Protoc 2: 1508-1514, 2007 (Pubitemid 46952329)